Search
Theratechnologies Inc
THTXAdd to Watchlist
3.390USD
0.0000.00%
Close 07/02, 13:00（ET）Quotes delayed by 15 min
155.87MMarket Cap
LossP/E TTM
More Details of Theratechnologies Inc Company
Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.
Theratechnologies Inc Info
Ticker SymbolTHTX
Company nameTheratechnologies Inc
IPO dateDec 21, 1993
CEOMr. Paul Levesque
Number of employees94
Security typeOrdinary Share
Fiscal year-endDec 21
Address2015 Peel Street, 11th Floor
CityMONTREAL
Stock exchangeNASDAQ Capital Market Consolidated
CountryCanada
Postal codeH3A 1T8
Phone15143367800
Websitehttps://www.theratech.com/
Ticker SymbolTHTX
IPO dateDec 21, 1993
CEOMr. Paul Levesque
Company Executives of Theratechnologies Inc
Name
Name/Position
Position
Shareholding
Change
Mr. Jocelyn Lafond
Mr. Jocelyn Lafond
General Counsel, Company Secretary
General Counsel, Company Secretary
--
-100.00%
Mr. Joseph P. Arena
Mr. Joseph P. Arena
Independent Director
Independent Director
--
--
Mr. John Leasure
Mr. John Leasure
Global Commercial Officer
Global Commercial Officer
--
-100.00%
Mr. Paul Levesque
Mr. Paul Levesque
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
--
-100.00%
Mr. Frank A. Holler
Mr. Frank A. Holler
Independent Non-Executive Chairman of the Board
Independent Non-Executive Chairman of the Board
--
-100.00%
Dr. Christian Marsolais, Ph.D.
Dr. Christian Marsolais, Ph.D.
Senior Vice President, Chief Medical Officer
Senior Vice President, Chief Medical Officer
--
-100.00%
Ms. Dale Maccandlish Weil
Ms. Dale Maccandlish Weil
Independent Director
Independent Director
--
-100.00%
Mr. Andre Dupras
Mr. Andre Dupras
Vice President of Human Resources
Vice President of Human Resources
--
--
Ms. Elina Tea
Ms. Elina Tea
Independent Director
Independent Director
--
--
Mr. Andrew Thomas Molson
Mr. Andrew Thomas Molson
Independent Director
Independent Director
--
-100.00%
View more
Name
Name/Position
Position
Shareholding
Change
Mr. Jocelyn Lafond
Mr. Jocelyn Lafond
General Counsel, Company Secretary
General Counsel, Company Secretary
--
-100.00%
Mr. Joseph P. Arena
Mr. Joseph P. Arena
Independent Director
Independent Director
--
--
Mr. John Leasure
Mr. John Leasure
Global Commercial Officer
Global Commercial Officer
--
-100.00%
Mr. Paul Levesque
Mr. Paul Levesque
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
--
-100.00%
Mr. Frank A. Holler
Mr. Frank A. Holler
Independent Non-Executive Chairman of the Board
Independent Non-Executive Chairman of the Board
--
-100.00%
Dr. Christian Marsolais, Ph.D.
Dr. Christian Marsolais, Ph.D.
Senior Vice President, Chief Medical Officer
Senior Vice President, Chief Medical Officer
--
-100.00%
FAQs
Who are the top five shareholders of Theratechnologies Inc?
The top five shareholders of Theratechnologies Inc are: Mr. Jocelyn Lafond
How many institutions hold shares of Theratechnologies Inc (THTX)?
As of 2026Q1, 78 institutions hold shares of Theratechnologies Inc, with a combined market value of approximately 293.53K, accounting for 0.64% of the total shares. Compared to 2025Q4, institutional shareholding has increased by -22862543.00.
What is the biggest source of revenue for Theratechnologies Inc?
In 2026Q1, the EGRIFTA business generated the highest revenue for Theratechnologies Inc, amounting to 11.13M and accounting for 62.78% of total revenue.